Position in GILD
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$360,068
+$28,229 QoQ
Shares Held
2,850
+19.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#1,552
of 2,266 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 6%
Shared 0%
None 94%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CAMDEN NATIONAL BANK holds $48,743,727 across 8 Drug Manufacturers - General names. GILD ranks #6 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
69,914 | $17,756,057 | |
| 2 | MRK |
Merck & Co., Inc.
|
113,039 | $14,525,511 | |
| 3 | NVS |
Novartis AG
|
70,745 | $11,087,156 | |
| 4 | ABBV |
AbbVie Inc.
|
9,869 | $2,483,434 | |
| 5 | LLY |
ELI LILLY & Co
|
1,578 | $1,892,700 | |
| 6 | GILD |
Gilead Sciences, Inc.
This page
|
2,850 | $360,068 | |
| 7 | PFE |
Pfizer Inc
|
14,370 | $346,029 | |
| 8 | AZN |
Astrazeneca PLC
|
1,544 | $292,772 |
All Filings in GILD
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $360,068 | 2,850 | Shares | Defined | 2026-07-31 | |
| 2026-03-31 | $331,839 | 2,381 | Shares | Defined | 2026-05-04 | |
| 2025-12-31 | $298,380 | 2,431 | Shares | Defined | 2026-02-10 | |
| No filing history on record for this holder in this stock. | ||||||